Foundation Medicine Company
Founded in 2010 in Cambridge, Massachusetts, Foundation Medicine develops comprehensive genomic profiling (CGP) tests for cancer. Its flagship assay, FoundationOne® CDx, analyzes hundreds of cancer-related genes to guide targeted therapies and immuno-oncology treatments. Acquired by Roche in 2018, it operates as a leading precision-oncology diagnostics company, integrating into clinical practice worldwide. (foundationmedicine.com)
Investors
Connections from
Headquarters:
Boston, Massachusetts · 400 Summer Street, Boston, MA 02210
Founded Date:
2010
Estimated Revenue:
No public info